Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
05/2011
05/25/2011CN102076717A Cross-linkers and their uses
05/25/2011CN102070135A Amphiphilic porous hollow carbon microsphere as well as preparation method and application thereof
05/25/2011CN101529227B A microarray system and a process for producing microarrays
05/25/2011CN101306352B Large particle diameter mono-disperse polymer microspheres containing epoxy group and preparation method thereof
05/24/2011US7947812 Neoplasm specific antibodies and uses thereof
05/24/2011US7947804 Vesicle trafficking proteins
05/24/2011US7947645 APO E analogs and methods for their use
05/24/2011US7947290 Protease-resistant modified SEB and vaccine containing the same
05/24/2011CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
05/24/2011CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof
05/24/2011CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
05/19/2011WO2011058315A2 Glucose sensor
05/19/2011US20110117105 Method of treating immune disease using b-cell antibodies
05/19/2011US20110117029 Water-soluble anionic bacteriochlorophyll derivatives and their uses
05/19/2011CA2780493A1 Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures
05/17/2011US7943745 Anti-CD98 antibody
05/17/2011US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation
05/17/2011US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
05/17/2011US7943129 Single-domain brain-targeting antibody fragments derived from llama antibodies
05/12/2011WO2011055682A1 Multilayer transparent light-receiving element and electronic device
05/12/2011US20110111985 Biosensor
05/12/2011CA2780163A1 Method for treating heart failure with stresscopin-like peptides
05/11/2011CN101565469B Acid amide-grafted sodium alginate nanometer material, preparation method thereof and use thereof
05/10/2011US7939643 Production of a von Willebrand factor preparation using hydroxylapatite
05/10/2011US7939635 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
05/10/2011US7939624 Peptide able to break the m-p53/p63, m-p53/p73 and m-p53/respective isoform proteins complex formed in the tumor cells and uses thereof in the pharmacological field
05/10/2011US7939500 Antifungal paints and coatings
05/10/2011US7939492 Factor C for treating gram-negative bacterial infection
05/10/2011US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
05/10/2011CA2342979C Chemiluminescent 1,2-dioxetanes
05/05/2011US20110105730 Affinity chromatography matrices and methods of making and using the same
05/05/2011US20110104783 Stereoisomer peptides, ligand-targeted multi- stereoisomer peptide polymer conjugates, and uses thereof
05/05/2011US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds
05/05/2011US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
05/04/2011EP2316850A2 HASylated polypeptides, especially HASylated erythropoietin
05/04/2011EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
05/03/2011US7935659 Multiplexed assays using encoded solid supports
05/03/2011US7935347 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases
04/2011
04/28/2011US20110097302 Il-1ra-polymer conjugates
04/28/2011CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof
04/27/2011EP2315026A2 Taxol immunoassay
04/27/2011EP2314681A1 Modified biotin-binding protein
04/27/2011CN102037012A Anti-tnfa antibody
04/26/2011US7932365 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
04/26/2011US7932230 Antifungal paints and coatings
04/26/2011CA2446112C A method for regulating immune function in primates using the foxp3 protein
04/21/2011WO2010138522A3 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
04/21/2011US20110092679 Dark Quenchers For Donor-Acceptor Energy Transfer
04/21/2011US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders
04/20/2011EP2311939A1 Polypeptide immobilization
04/20/2011EP2311882A1 Reducing the immunogenicity of fusion proteins
04/20/2011EP2310062A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness
04/20/2011EP1639141B1 Methods for treating lentivirus infections
04/20/2011CN102027019A High-density lipoprotein-like peptide-phospholipid scaffold (''HPPS'') nanoparticles
04/20/2011CN101240027B Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine
04/19/2011US7928186 Cell permeable bioactive peptide conjugates
04/19/2011US7927825 Methods of using T1R2/T1R3 heteromeric receptors to quantify taste of compounds for food or beverages
04/19/2011US7927821 Methods of screening for compounds which bind G protein-coupled receptors
04/19/2011US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers
04/14/2011WO2011041906A1 Surface-coated structures and methods
04/14/2011WO2011041897A1 Compositions and methods for the transport of therapeutic agents
04/14/2011WO2011015530A3 Process for deposition of thin layers of metal oxides
04/14/2011US20110087321 Surface-coated structures and methods
04/14/2011US20110086404 Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-r prothrombin activation peptide fragment f2 (des-r f2) in a serum
04/14/2011US20110085979 Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions
04/14/2011CA2777100A1 Surface-coated structures and methods
04/14/2011CA2777096A1 Compositions and methods for the transport of therapeutic agents
04/13/2011EP2308900A2 Immunogenic compositions and methods of use
04/13/2011EP2308889A1 Isoforms of brain natriuretic peptide
04/13/2011CN102016586A Use of synthetic peptide derived from ZEBRA protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation
04/13/2011CN102016020A Surfaces with immobilized enzymes or anti-icing proteins
04/12/2011US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer
04/12/2011US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
04/12/2011CA2434060C Preparation of a therapeutic composition
04/07/2011WO2011040823A1 Synthetic myostatin peptide antagonists
04/07/2011WO2010121352A8 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
04/07/2011US20110082077 Sialic acid derivatives for protein derivatisation and conjugation
04/07/2011DE20321836U1 Hydroxyalkylstärkederivate Hydroxyalkylstärkederivate
04/07/2011CA2776529A1 Synthetic myostatin peptide antagonists
04/07/2011CA2776503A1 Compositions and methods for enhancing coagulation factor viii function
04/06/2011EP2305804A1 MonoPEGylated human growth hormone
04/06/2011EP2304440A1 Novel monoclonal antibodies against hpv proteins
04/06/2011EP2303927A2 Molecularly imprinted polymers for detecting microorganisms
04/05/2011US7919594 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders
04/05/2011US7919588 Netrin receptors
04/05/2011US7919263 Organic material-immobiling structure and method for production of the same, and peptide and DNA therefor
04/05/2011CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
03/2011
03/31/2011WO2011037896A2 Polypeptide modification
03/31/2011US20110077385 Protein arrays
03/31/2011US20110076737 Carriers for immobilization and reusability of enzymes
03/31/2011US20110076287 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
03/31/2011CA2775287A1 Polypeptide modification
03/30/2011EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization
03/30/2011EP2301564A1 Compositions and methods for promoting neuronal outgrowth
03/30/2011CN101993867A Immobilization method using chitosan as carrier
03/30/2011CN101993494A N-terminal chemical modification and application of human fibroblast growth factor-21 (hFGF-21)
03/30/2011CN101993485A Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof
03/29/2011US7915052 Immunoglobulin peptides against heated bovine blood
03/29/2011US7914802 Mucosal vaccine adjuvants containing bacterial flagellins as an active component
03/24/2011US20110072526 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 107